Revenue Memorandum Circular No. 62-2020
Publishing the full text of the letter from the Food and Drug Administration (FDA) of the Department of Health (DOH) containing the “List of Prescription Drugs and Medicine for Diabetes, High-Cholesterol and Hypertension Exempt from VAT beginning January 27, 2020” pursuant to Section 1 Republic Act No. 11467
REVENUE MEMORANDUM CIRCULAR NO. 61-2020
issued on June 15, 2020 further extends the deadline for availment of Tax Amnesty on Delinquencies provided under RR No. 4-2019, as amended,from June 22, 2020 to December 31, 2020.
SEC Notice (June 23, 2020)
PROPOSED GUIDELINES FOR CONVERSION OF CORPORATION EITHER TO ONE PERSON CORPORATION OR TO ORDINARY STOCK CORPORATION
BIR Memorandum Circular No. 60-2020
Obligation of Persons Conducting Business Transaction Through Any Forms of Electronic Media, and Notice to Unregistered Business
BIR Revenue Memorandum Circular No. 59-2020
Amending the Provision of Revenue Memorandum Circular (RMC) No. 47-2020 Relative to the Temporary Measures Adopted by Taxpayers on the Receipting/Invoicing Requirements Pursuant to Republic Act. No. 11469 also known as “Bayanihan to Heal As One Act”
